Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrea Lukes

Gynecology Durham, NC Medical Doctor

NPI 1669556718 CMS profile 211099

249 E Nc Highway 54, Suite 330, Durham, NC 27713

Open in the dashboard

General payments

$289,733

401 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$5

5 holdings reported · through program year 2025

Research they led as principal investigator

$1,851,220 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Andrea Lukes of Durham, NC is reported in the CMS Open Payments database as having received $289,733 across 401 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,851,220 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $5 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,623 42
2024 General $2,751 44
2023 General $22,469 47
2022 General $44,222 48
2021 General $86,375 79
2020 General $35,654 40
2019 General $90,639 101
2024 Ownership $1 1
2023 Ownership $1 1
2022 Ownership $1 1
2021 Ownership $1 1
2020 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrea Lukes
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Andrea Lukes were reported at $7,623. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Andrea Lukes Gynecology median Middle half National median
2019 $90,639 $199 $66–$472 $163
2020 $35,654 $114 $42–$287 $114
2021 $86,375 $141 $42–$430 $132
2022 $44,222 $173 $52–$532 $149
2023 $22,469 $170 $57–$501 $160
2024 $2,751 $157 $50–$424 $164
2025 $7,623 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $175,793 218 payments
  2. Myovant Sciences Inc. $63,833 51 payments
  3. Sumitomo Pharma America, Inc. $17,123 20 payments
  4. Pfizer Inc. $13,841 22 payments
  5. Whitehall International Inc $8,000 2 payments
  6. Alnylam Pharmaceuticals Inc. $3,910 2 payments
  7. Myovant Sciences GmbH $3,801 2 payments
  8. Bayer HealthCare Pharmaceuticals Inc. $1,890 3 payments
  9. Novo Nordisk Inc $429 25 payments
  10. Astellas Pharma US Inc $192 6 payments
  11. Other $922 50 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $226,249 102 payments
  2. Consulting Fee $26,611 8 payments
  3. Travel and Lodging $26,393 55 payments
  4. Food and Beverage $6,809 229 payments
  5. Honoraria $3,500 1 payment
  6. Education $170 6 payments
Products named General payments · program years 2019–2025
  1. Orilissa Endocrinology $90,520 93 payments
  2. ORIAHNN $53,149 51 payments
  3. ORILISSA Womens Health $53,046 63 payments
  4. MYFEMBREE Hormone Therapy $48,714 57 payments
  5. MYFEMBREE Genitourinary (Sexual Health);Womens Health $21,595 11 payments
  6. Lynkuet $1,852 1 payment
  7. UBRELVY $298 19 payments
  8. NURTEC ODT $286 15 payments
  9. QULIPTA $241 16 payments
  10. ZAVZPRET $214 11 payments
  11. Other $2,422 134 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$3,424

Medicare's payments for the services billed

Medicare patients

22

Average age 70

Services billed

59

22 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 50%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MYFEMBREE
  • WHITEHALL INTERNATIONAL INC $2,000
  • Sumitomo Pharma America, Inc. $24
  • PFIZER INC. $23
$2,047 — —
Wegovy
  • Novo Nordisk Inc $104
$104 — —
UBRELVY
  • AbbVie, Inc. $77
$77 — —
NURTEC ODT
  • PFIZER INC. $63
$63 — —
Veozah
  • Astellas Pharma US Inc $62
$62 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

401 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record